Cardio Diagnostics Inc.
CDIO | NASDAQ
$1.92
-$0.10 (-4.95%)
At close: Sep 21, 2026, 4:00 PM ET
$2
+$0.08 (+4.17%)
After-hours:
Sep 21, 2026, 7:04 PM ET
Company Profile
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Key Executives
| Name | Position |
|---|---|
| Meeshanthini Dogan | Co-Founder, Chief Executive Officer & Director |
| Elisa Michael Luqman | Chief Financial Officer & Principal Accounting Officer |
| Timur Dogan | Chief Technology Officer |
| Robert A. Philibert | Co-Founder, Chief Medical Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 20, 2026 | 8-K | Current Report |
| Aug 07, 2026 | 10-Q | Quarterly Report |
| Aug 07, 2026 | DEFA14A | Filing |
| Aug 05, 2026 | DEF 14A | Filing |
| Jul 23, 2026 | ARS | Filing |
| Jul 13, 2026 | PRE 14A | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
| Jul 02, 2026 | 4 | Filing |
Cardio Diagnostics Inc.
| Country | United States |
| IPO Date | Jan 13, 2022 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 15 |
| CEO | Meeshanthini V. Dogan |
Contact Details
311 West Superior Street Chicago,
Illinois 60654 United States
Stock Details
| Ticker Symbol | CDIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001870144 |
| CUSIP Number | 14159C202 |
| ISIN Number | US14159C2026 |
| SIC Code | 2835 |
Add to Watchlist
Select watchlists to add or remove CDIO